Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Combaret, Valérie" or (type exact bookEditor and editor="Combaret, Valérie")

Mark
- journalArticle
- A1
- open access
Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients

Pauline Depuydt (UGent) , Valentina Boeva, Toby D Hocking, Robrecht Cannoodt (UGent) , Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2018) JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 110(10).
Mark
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Fjoralba Zeka (UGent) , Anneleen Decock (UGent) , Alan Van Goethem (UGent) , Katrien Vanderheyden, Fleur Demuynck, Tim Lammens (UGent) , Hetty Helsmoortel (UGent) , Joëlle Vermeulen, Rosa Noguera, Ana P. Berbegall, et al.

(2018) JCI INSIGHT. 3(23).
Mark
- conference
- C3
Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients

Pauline Depuydt (UGent) , Valentina Boeva, Toby D Hocking, Robrecht Cannoodt (UGent) , Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2017) Cancer Genomics, 3rd EACR conference, Abstracts.
Mark
- conference
- C3
Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets

Pauline Depuydt (UGent) , Valentina Boeva, Toby Hocking, Robrecht Cannoodt (UGent) , Inge Ambros, Peter Ambros, Shahab Asgharzadeh, Edward Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2017) Big Data in Biology and Health, Abstracts.
Mark
- journalArticle
- A1
- open access
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Robrecht Cannoodt (UGent) , Kimberly Verniers (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Ana Pilar Berbegall, Julie Bienertova-Vasku, Nick Bown, et al.

(2016) ONCOTARGET. 7(2). p.1960-1972
Mark
- conference
- C3
Distal chromosome 6q deletion defines a group of ultra-high risk neuroblastoma patients

Pauline Depuydt (UGent) , Valentina Boeva, Toby D Hocking, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, Matthias Fischer, Michael D Hogarty, et al.

(2016) Advances in Neuroblastoma Research, Congress abstracts.
Mark
- conference
- C3
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Robrecht Cannoodt (UGent) , Kimberly Verniers (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Ana Pilar Berbegall, Julie Bienertova-Vasku, Nick Bown, et al.

(2016) OncoPoint, 4th Research seminar, Abstracts.
Mark
- conference
- C3
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Robrecht Cannoodt (UGent) , Kimberly Verniers (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Ana Pilar Berbegall, Julie Bienertova-Vasku, Nick Bown, et al.

(2015) European Cancer Epigenetics conference, 1st, Abstracts.
Mark
- conference
- C3
Genome-wide methylation analysis unravels differential DNA methylation patterns between (prognostic) neuroblastoma patient subgroups

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Ana Berbegall, Rosa Noguera, Jayne Murray, Michele Haber, Raymond L Stallings, Johannes H Schulte, Valérie Combaret, Gudrun Schleiermacher, et al.

(2014) ANR Cologne 2014 : information book.
Mark
Emergence of new ALK mutations at relapse of neuroblastoma

Gudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, Quentin Leroy, Julie Cappo, Thomas Rio Frio, Gaëlle Pierron, Eve Lapouble, Valérie Combaret, Franki Speleman (UGent) , et al.

(2014) JOURNAL OF CLINICAL ONCOLOGY. 32(25). p.2727-2734

Academic Bibliography

Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients

Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Distal chromosome 6q deletion defines a group of ultra-high risk neuroblastoma patients

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Genome-wide methylation analysis unravels differential DNA methylation patterns between (prognostic) neuroblastoma patient subgroups

Emergence of new ALK mutations at relapse of neuroblastoma

Contents

Support

Contact